News

orange__line
The AZENT Study

We are pleased to announce that AZENT study "A phase IIa clinical trial to evaluate the safety and efficacy of osimertinib (AZD9291) in first-line patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer...
READ MORE...
MedSIR INSIDE OUT – Christian Gonzalez

Today we are happy to interview our new Business Development guy, Christian Gonzalez. MedSIR Newsletter Team (MS): Thanks, Christian, for spending some time with us here today. Christian Gonzalez (CG)...
READ MORE...
The Kelly Study

This a multicenter, open-label, phase II clinical trial to assess the efficacy of pembrolizumab in combination with eribulin in female patients with hormone receptor-(HR) positive/HER2-negative metastatic breast cancer (MBC) previously treated with...
READ MORE...
The BioPER study

“A Multicentre, International, Non-controlled Phase II Trial to Identify the Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge Upon Progression to a Palbociclib Combination in ER-positive Metastatic Breast Cancer...
READ MORE...
The PHERGain Study

We are pleased to announce that PHERGain study “Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive (Human Epidermal Receptor) Breast Cancer: FDG-PET Response-adapted Strategy” has achieved 40% of recruitment!!
READ MORE...
Dietary supplements and cancer: promises and realities

A dietary supplement can be defined as any vitamin, mineral, protein, enzyme, probiotic, herb, or plant substance taken to supplement dietary needs or improve body functions. Although some dietary supplements...
READ MORE...
MedSIR INSIDE OUT – Alicia Garcia

Today we are happy to spend a brief moment with Alicia Garcia, Head of Clinical Operations at MedSIR. MedSIR Newsletter Team (MS): Thanks, Alicia, for spending some time with us here today. Alicia Garcia (AG): Thank you...
READ MORE...
Post ASCO 2018

Barely 8 weeks after visiting the city for the AACR 2018 annual meeting, MedSIR returned to Chicago for ASCO 2018! McCormick Place is the largest convention center in North America, but at MedSIR we feel we already know all its nooks and crannies!
READ MORE...
INTERVIEW: Oncologist of the Month – Dr. María Jesus Rubio Perez

Today, we had the chance to sit down with Dr. Mª Jesús Rubio Pérez, Gynecological Cancer Specialist and our MedSIR Oncologist of the Month. Here’s an excerpt...
READ MORE...